| Financial Year |
March 31 2023 |
| Monetary Funds |
141,834,538.31 |
| Held-for-trading Financial Assets |
4,000.00 |
| Notes Receivable |
123,959,992.22 |
| Accounts Receivable |
378,529,968.89 |
| Advances to Suppliers |
2,888,417.28 |
| Other Receivables |
21,405,888.24 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
310,940,541.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,949,941.60 |
| Total Current Assets |
1,036,190,021.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,618,332.69 |
| Investment Properties |
-- |
| Fixed Assetes |
771,384,223.96 |
| Under-construction Projects |
145,370,078.80 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
155,192,424.39 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
77,520,957.44 |
| Deferred Income Tax Assets |
17,733,863.59 |
| Other Non-Current Assets |
27,950,699.37 |
| Sub-Total of Non-Current Assets |
1,347,600,825.84 |
| Total Assets |
2,383,790,847.26 |
| Short-Term Loans |
228,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
222,671,603.21 |
| Accounts Payable |
613,813,505.27 |
| Accounts Received In Advance |
10,785.33 |
| Employee Compensation Payable |
38,330,091.82 |
| Taxes Payable |
7,768,791.74 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
66,256,370.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
39,882,075.12 |
| Other Current Liabilities |
4,754,655.56 |
| Sub-Total of Current Liabilities |
1,228,266,358.39 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
338,685.51 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
161,287,262.97 |
| Total Liabilities |
1,389,553,621.36 |
| Paid-In Capital(Or Share Stock) |
246,419,682.00 |
| Capital Surplus |
552,354,736.88 |
| Surplus Reserve |
41,965,010.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
146,852,115.83 |
| Minority Stockholder's Interest |
7,613,020.15 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
986,624,205.75 |
| Owner's Equity（Stockholder's Equity） |
994,237,225.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,383,790,847.26 |
